Journal of Mahatma Gandhi University of Medical Sciences and Technology

Register      Login

VOLUME 6 , ISSUE 2 ( May-August, 2021 ) > List of Articles

RESEARCH ARTICLE

Role of Hematological Indices in COVID-19 Patient\'s Prognosis

Chakrapani Mittal, Aviral Gupta, Shrikant Choudhary, Mukesh Sarna, Aakriti Vij

Keywords : Coronavirus disease 2019, Hematological indices, Neutrophil:lymphocyte ratio, Platelet:lymphocyte ratio

Citation Information : Mittal C, Gupta A, Choudhary S, Sarna M, Vij A. Role of Hematological Indices in COVID-19 Patient\'s Prognosis. J Mahatma Gandhi Univ Med Sci Tech 2021; 6 (2):39-41.

DOI: 10.5005/jp-journals-10057-0155

License: CC BY-NC 4.0

Published Online: 31-08-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim and background: In this study, the role of hematological indices in coronavirus disease 2019 (COVID-19) patients’ prognosis who have visited our hospital has been evaluated. Materials and methods: Clinical profile, disease severity, disease outcome, blood parameters [hemoglobin, white blood cell counts, neutrophil counts, lymphocyte counts, neutrophil:lymphocyte ratio (NLR), lymphocyte:monocyte ratio, platelet counts, eosinophil count, and platelet:lymphocyte ratio (PLR)] were evaluated in patients with confirmed COVID-19 infection. Results: High values of leukocytes, neutrophils, and low value of platelets, eosinophil counts indicated poor prognosis in COVID-19 patients. High NLR, PLR, and low lymphocyte:monocyte ratio also indicated a bad prognosis. Conclusion: Monocyte count, lymphocyte count, eosinophil count, NLR, lymphocyte monocyte ratio, and PLR values can be used in the prognosis of COVID-19 patients.


PDF Share
  1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199–1207. DOI: 10.1056/NEJMoa2001316.
  2. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020;92(4):401–402.
  3. Prevention CfDCa, First travel-related Case of 2019 Novel Coronavirus Detected in United States. U.S. Department of Health & Human Services 2020 [Available from: http://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html.
  4. WHO, Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) 2020 [Available from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
  5. Bennett JDR, Blaser MJ. Principles and practice of infectious diseases. 8th ed., PA, USA: Elsevier/Saunders; 2014.
  6. Lu R, Yu X, Wang W, et al. Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays. PLoS One 2012;7(6):e38638. DOI: 10.1371/journal.pone.0038638.
  7. Bekdas M, Goksugur SB, Sarac EG, et al. Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children. Saudi Med J 2014;35(5):442–447.
  8. Ilhan M, Ilhan G, Gok AF, et al. Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio as early predictor of acute pancreatitis in pregnancy. J Matern Fetal Neonatal Med 2016;29(9):1476–1480. DOI: 10.3109/14767058.2015.1051026.
  9. Yazar FM, Bakacak M, Emre A, et al. Predictive role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for diagnosis of acute appendicitis during pregnancy. Kaohsiung J Med Sci 2015;31(11):591–596. DOI: 10.1016/j.kjms.2015.10.005.
  10. Xiang N, Havers F, Chen T, et al. Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. Emerg Infect Dis 2013;19(11):1784–1790. DOI: 10.3201/eid1911.130865.
  11. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032.
  12. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13(9):752–761. DOI: 10.1016/S1473-3099(13)70204-4.
  13. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606. DOI: 10.1136/bmj.m606.
  14. Xu Y, Zhang Y, Jiang F, et al. Comparison of relevant indicators of coagulation and fibrinolysis in patients with varying severity of community-acquired pneumonia. Zhonghua Yi Xue Za Zhi 2015;95(24):1925–1929.
  15. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020;95(6):E131–E134. DOI: 10.1002/ajh.25774.
  16. Loonen AJM, de Jager CPC, Tosserams J, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One 2014;9(1):e87315. DOI: 10.1371/journal.pone.0087315.
  17. Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med 2013;33(2):105–110. DOI: 10.3343/alm.2013.33.2.105.
  18. Naess A, Mo R, Nilssen SS, et al. Infections in patients hospitalized for fever as related to duration and other predictors at admittance. Infection 2014;42(3):485–492. DOI: 10.1007/s15010-013-0573-1.
  19. Zhang Y, Zou P, Gao H, et al. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study. Ther Clin Risk Manag 2019;15:911–919. DOI: 10.2147/TCRM. S206930.
  20. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. DOI: 10.1016/j.intimp.2020.106504.
  21. Tanni F, Akker E, Zaman MM, et al. Eosinopenia and COVID-19. J Am Osteopath Assoc 2020. DOI: 10.7556/jaoa.2020.091Online ahead of print.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.